Glycoconjugates on extracellular vesicles (EVs) play a vital role in internalization and mediate interaction as well as regulation of the host immune system by viruses, bacteria, and parasites. During their intraerythrocytic life‐cycle stages, malaria parasites, Plasmodium falciparum (Pf) mediate the secretion of EVs by infected red blood cells (RBCs) that carry a diverse range of parasitic and host‐derived molecules. These molecules facilitate parasite‐parasite and parasite‐host interactions to ensure parasite survival.To date, the number of identified Pf genes associated with glycan synthesis and the repertoire of expressed glycoconjugates is relatively low. Moreover, the role of Pf glycans in pathogenesis is mostly unclear and poorly understood. As a result, the expression of glycoconjugates on Pf‐derived EVs or their involvement in the parasite life‐cycle has yet to be reported.Herein, we show that EVs secreted by Pf‐infected RBCs carry significantly higher sialylated complex N‐glycans than EVs derived from healthy RBCs. Furthermore, we reveal that EV uptake by host monocytes depends on N‐glycoproteins and demonstrate that terminal sialic acid on the N‐glycans is essential for uptake by human monocytes. Our results provide the first evidence that Pf exploits host sialylated N‐glycans to mediate EV uptake by the human immune system cells.
The identification
of tumor-specific biomarkers is one of the bottlenecks
in the development of cancer therapies. Previous work revealed altered
surface levels of reduced/oxidized cysteines in many cancers due to
overexpression of redox-controlling proteins such as protein disulfide
isomerases on the cell surface. Alterations in surface thiols can
promote cell adhesion and metastasis, making thiols attractive targets
for treatment. Few tools are available to study surface thiols on
cancer cells and exploit them for theranostics. Here, we describe
a nanobody (CB2) that specifically recognizes B cell lymphoma and
breast cancer in a thiol-dependent manner. CB2 binding strictly requires
the presence of a nonconserved cysteine in the antigen-binding region
and correlates with elevated surface levels of free thiols on B cell
lymphoma compared to healthy lymphocytes. Nanobody CB2 can induce
complement-dependent cytotoxicity against lymphoma cells when functionalized
with synthetic rhamnose trimers. Lymphoma cells internalize CB2 via
thiol-mediated endocytosis which can be exploited to deliver cytotoxic
agents. CB2 internalization combined with functionalization forms
the basis for a wide range of diagnostic and therapeutic applications,
rendering thiol-reactive nanobodies promising tools for targeting
cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.